Headache Attributed to Temporomandibular Disorders: Axis I and II Findings According to the Diagnostic Criteria for Temporomandibular Disorders

Aims: To analyze Axis I and II findings of patients diagnosed as having painful temporomandibular disorder (TMD) with headache attributed to TMD (HAattrTMD) in order to assess whether HAattrTMD is associated with a specific Axis I and II profile suggestive of the central sensitization process. Methods: This retrospective study included 220 patients with painful TMD divided into those with (n = 60) and those without (n = 160) HAattrTMD, and the patients were compared for Axis I and II results according to the Diagnostic Criteria for TMD (DC/TMD). A P value < .05 was considered statistically significant. Results: A total of 27.3% of the patients received a diagnosis of HAattrTMD. Myofascial pain with referral was significantly more common in the HAattrTMD group (P < .001), while local myalgia was significantly more common in the non-HAattrTMD group (P < .001). Characteristic pain intensity was significantly higher in the HAattrTMD group (P = .003), which also showed significantly higher levels of depression (P = .002), nonspecific physical symptoms (P = .004), graded chronic pain (P = .008), and pain catastrophizing (P = .013). Nonspecific physical symptoms were positively associated with HAattrTMD (odds ratio [OR] = 1.098, 95% CI = 1.006 to 1.200, P = .037). Local myalgia was negatively associated with HAattrTMD (OR = .295, 95% CI = 0.098 to 0.887, P = .030). Conclusions: Painful TMD patients who report headache in the temple area and are diagnosed as having local myalgia rather than myofascial pain with referral probably do not have HAattrTMD. The diagnosis of HAattrTMD may point to a central sensitization process and possible current/future chronic TMD conditions.

Axis II; DC/TMD; headache attributed to TMD; local myalgia; myofascial pain with referral

1. Stovner LJ, Andree C. Prevalence of headache in Europe: A review for the Eurolight project. J Headache Pain 2010;11: 289–299.

2. Steiner TJ, Stovner LJ, Katsarava Z, et al. The impact of headache in Europe: Principal results of the Eurolight project. J Headache Pain 2014;15:31.

3. National Institute of Dental and Craniofacial Research. Facial pain. https://www.nidcr.nih.gov/research/data-statistics/facialpain. Updated July 2018. Accessed March 3, 2021.

4. Dworkin SF, Huggins KH, LeResche L, et al. Epidemiology of signs and symptoms in temporomandibular disorders: Clinicalsigns in cases and controls. J Am Dent Assoc 1990;120:273–281.

5. Ashina S, Bendtsen L, Lyngberg AC, Lipton RB, Hajiyeva N, Jensen R. Prevalence of neck pain in migraine and tension-type headache: A population study. Cephalalgia 2015;35:211–219.

6. Hagen K, Einarsen C, Zwart JA, Svebak S, Bovim G. The co occurrence of headache and musculoskeletal symptoms amongst 51 050 adults in Norway. Eur J Neurol 2002;9:527–533.

7. Haley D, Schiffman E, Baker C, Belgrade M. The comparison of patients suffering from temporomandibular disorders and a general headache population. Headache 1993;33:210–213.

8. Schokker RP, Hansson TL, Ansink BJ. Craniomandibular disorders in patients with different types of headache. J Craniomandib Disord 1990;4:47–51.

9. Glaros AG, Urban D, Locke J. Headache and temporomandibular disorders: Evidence for diagnostic and behavioural overlap. Cephalalgia 2007;27:542–549.

10. Ballegaard V, Thede-Schmidt-Hansen P, Svensson P, Jensen R. Are headache and temporomandibular disorders related? A blinded study. Cephalalgia 2008;28:832–841.

11. Gonçalves DA, Bigal ME, Jales LC, Camparis CM, Speciali JG. Headache and symptoms of temporomandibular disorder: Anepidemiological study. Headache 2010;50:231–241.

12. Franco AL, Gonçalves DA, Castanharo SM, Speciali JG, Bigal ME, Camparis CM. Migraine is the most prevalent primary headache in individuals with temporomandibular disorders. J Orofac Pain 2010;24:287–292.

13. Anderson GC, John MT, Ohrbach R, et al. Influence of headache frequency on clinical signs and symptoms of TMD in subjects with temple headache and TMD pain. Pain 2011;152:765–771.

14. Marklund S, Wiesinger B, Wänman A. Reciprocal influence on the incidence of symptoms in trigeminally and spinally innervat-ed areas. Eur J Pain 2010;14:366–371.

15. Lim PF, Smith S, Bhalang K, Slade GD, Maixner W. Development of temporomandibular disorders is associated with greater bodily pain experience. Clin J Pain 2010;26:116–120.

16. Schokker RP, Hansson TL, Ansink BJ. The result of treatment of the masticatory system of chronic headache patients. J Craniomandib Disord 1990;4:126–130.

17. Hara K, Shinozaki T, Okada-Ogawa A, et al. Headache attributed to temporomandibular disorders and masticatory myofascial pain. J Oral Sci 2016;58:195–204.

18. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 (suppl 1):9–160.

19. Schiffman E, Ohrbach R, List T, et al. Diagnostic criteria for headache attributed to temporomandibular disorders. Cephalalgia 2012;32:683–692.

20. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808.

21. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1–211.

22. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

23. Conti PC, Costa YM, Gonçalves DA, Svensson P. Headaches and myofascial temporomandibular disorders: overlapping entities, separate managements? J Oral Rehabil 2016; 43:702–715.

24. List T, Jensen RH. Temporomandibular disorders: Old ideas and new concepts. Cephalalgia 2017;37:692–704.

25. Sessle BJ. Orofacial Pain: Recent Advances in Assessment, Management, and Understanding of Mechanisms. Washington, DC: IASP, 2014.

26. Friction JR, Schiffman EL. Epidemiology of temporomandibular disorders. In: Fricton JR, Dubner R (eds). Orofacial Pain andTemporomandibular Disorders. New York: Raven Press, 1995:1–14.

27. Ohrbach R, Dworkin SF. Five-year outcomes in TMD: Relationship of changes in pain to changes in physical and psychological variables. Pain 1998;74:315–326.

28. Epker J, Gatchel RJ, Ellis E 3rd. A model for predicting chronic TMD: Practical application in clinical settings. J Am Dent Assoc 1999;130:1470–1475.

29. Ohrbach R (ed). Diagnostic Criteria for Temporomandibular Disorders: Assessment Instruments (Hebrew). Translation by: Reiter S, Winocur E, Emodi-Perlman A. May 2016. https://buffalo.app.box.com/s/la73mwnkty9jjcn8yehcx0om2t85v9rg. Accessed March 3, 2021.

30. Sullivan MJ, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess 1995;7:524–532.

31. Svechtarov V, Nencheva-Svechtarova S, Uzunov, T. Analysis of chronic temporomandibular disorders based on the latest diagnostic criteria. Acta Medica Bulgarica 2015;42:49–55.

32. van der Meer HA, Speksnijder CM, Engelbert RH, Lobbezoo F, Nijhuis-van der Sanden MW, Visscher CM. The association between headaches and temporomandibular disorders is confounded by bruxism and somatic symptoms. Clin J Pain 2017;33:835–843.

33. Manfredini D, Guarda-Nardini L, Winocur E, Piccotti F, Ahlberg J, Lobbezoo F. Research Diagnostic Criteria for Temporomandibular Disorders: A systematic review of Axis I epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:453–462.

34. Vivaldi D, Di Giosia M, Tchivileva IE, Jay GW, Slade GD, Lim PF. Headache attributed to TMD is associated with the presence of comorbid bodily pain: A case-control study. Headache 2018;58:1593–1600.

35. Fernández-de-Las-Peñas C. Myofascial head pain. Curr Pain Headache Rep 2015;19:28.

36. Xu YM, Ge HY, Arendt-Nielsen L. Sustained nociceptive mechanical stimulation of latent myofascial trigger point induces central sensitization in healthy subjects. J Pain 2010;11:1348–1355.

37. Niddam DM, Chan RC, Lee SH, Yeh TC, Hsieh JC. Central representation of hyperalgesia from myofascial trigger point. Neuroimage 2008;39:1299–1306.

38. Niddam DM. Brain manifestation and modulation of pain from myofascial trigger points. Curr Pain Headache Rep 2009;13 :370–375.

39. Tension-type headache (TTH). In: Headache Classification Committee of the International Headaceh Society (IHS). The International Classification of Headache Disorders, ed 3. Cephalalgia 2018;38:35–40.

40. Crystal SC, Robbins MS. Tension-type headache mimics. Curr Pain Headache Rep 2011;15:459–466.

41. Do TP, Remmers A, Schytz HW, et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology 2019;92:134–144.

42. Yunus MB. Central sensitivity syndromes: A new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 2008;37:339–352.

43. Hara K, Shinozaki T, Okada-Ogawa A, et al. Headache attributed to temporomandibular disorders and masticatory myofascial pain. J Oral Sci 2016;58:195–204.

44. Schumann NP, Zwiener U, Nebrich A. Personality and quantified neuromuscular activity of the masticatory system in patients with temporomandibular joint dysfunction. J Oral Rehabil 1988;15:35–47.

45. Rudy TE, Turk DC, Zaki HS, Curtin HD. An empirical taxometric alternative to traditional classification of temporomandibular disorders. Pain 1989;36:311–320.

46. Etscheidt MA, Steger HG, Braverman B. Multidimensional Pain Inventory profile classifications and psychopathology. J Clin Psychol 1995;51:29–36.

47. Dworkin SF, LeResche L. Research Diagnostic Criteria for Temporomandibular Disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6:301–355.

48. Fillingim RB, Ohrbach R, Greenspan JD, et al. Potential psychosocial risk factors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011;12(11 suppl):T46–T60.